it has a steroid in it that thins the skin. Just use HQ & retin-A..u should be able to have similar results
Here's the results of a study that was done with Triluma:
Am J Dermatopathol. 2009 Sep 7. [Epub ahead of print]
A Histological Examination for Skin Atrophy After 6 Months of Treatment With Fluocinolone Acetonide 0.01%, Hydroquinone 4%, and Tretinoin 0.05% Cream.
Bhawan J, Grimes P, Pandya AG, Keady M, Byers HR, Guevara IL, ColÃ³n LE, Johnson LA, Gottschalk R.
From the *Dermatopathology Section, Department of Dermatology, Boston University School of Medicine, Boston, MA; daggerThe Vitiligo and Pigmentation Institute of Southern California, Los Angeles, CA; double daggerDepartment of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX; and section signGalderma Laboratories, L.P., Fort Worth, TX.
Melasma is a common disorder affecting a significant percentage of the population, particularly those with skin of color. Therapy with hydroquinone, a depigmenting agent, as a single agent or in combination with other agents has been used with variable success. A triple-combination (TC) cream combining hydroquinone 4% with tretinoin 0.05% and fluocinolone acetonide 0.01% was developed for the treatment of melasma. We studied the use of TC cream for 24 weeks and had tissue samples for all time points in 62 patients with moderate to severe melasma. The atrophogenic potential of TC cream was evaluated through serial histopathologic examination of skin biopsies. No statistically significant histopathologic signs of atrophy of the epidermis or dermis were noted at any time point throughout the study. There was a marked reduction in epidermal melanin in treated subjects; however, we did not observe any significant difference in baseline and treated samples in the amount of perivascular inflammatory infiltrate, dermal mucin, keratinocyte and melanocyte atypia, or mast cells, consistent with findings of previous studies where topical retinoids were used. An increase in the mean number of blood vessels per square millimeter of tissue was observed in 2 study cohorts between baseline and week 24. These results suggest that the risk of skin atrophy with 24-week use of TC cream for the treatment of melasma is very low.